Two Sigma Advisers
MXCT icon

Two Sigma Advisers’s MaxCyte MXCT Stock Holding History

Two Sigma Advisers’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-141,400
Closed -$219K – 1360
2025
Q4 		$219K Buy
+141,400
New +$226K ﹤0.01% 2090
2025
Q1 		– Sell
-17,800
Closed -$74K – 2517
2024
Q4 		$74K Buy
+17,800
New +$67.3K ﹤0.01% 2254
2024
Q2 		– Sell
-27,400
Closed -$115K – 2602
2024
Q1 		$115K Buy
27,400
+4,900
+22% +$23K ﹤0.01% 2294
2023
Q4 		$106K Buy
+22,500
New +$87.6K ﹤0.01% 2321

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $88.9M AUM

Two Sigma Advisers's MXCT Position: Q1 2026 in Review

Two Sigma Advisers sold out of MaxCyte (MXCT) in Q1 2026, closing a stake of 141,400 shares — an estimated $219K sold.

Two Sigma Advisers first reported a position in MXCT in Q4 2023 and held it in 4 quarters. The position peaked at $219K in Q4 2025. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • Two Sigma Advisers reported no remaining MaxCyte position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 141,400 MaxCyte shares in Q1 2026, an estimated $219K.
  • Two Sigma Advisers first reported a position in MaxCyte in Q4 2023 and held it in 4 quarters.
  • Two Sigma Advisers's MaxCyte position peaked at $219K in Q4 2025.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.